COUNCIL OF EUROPEAN BIOREGIONS

Their core work

The Council of European Bioregions is a Brussels-based NGO that represents and connects regional bioeconomy and innovation clusters across Europe. Their core function is facilitating cross-cluster collaboration — bridging regional industry networks with EU-level research programs in nanotechnology, advanced materials, and biotechnology. In practice, they appear in H2020 consortia to mobilize regional stakeholder communities, support dissemination into industry clusters, and give research consortia access to a pan-European network of bioregional actors. Their shift into nanotechnology-enabled medical devices suggests they are increasingly positioning their cluster networks as entry points for medtech and diagnostic innovation uptake.

What they specialise in

How they've shifted over time

In their first project (CLUSTERNANOROAD, 2016–2019), CEBR operated at the broad level of NMBP cluster economy development — no specific application keywords were recorded, suggesting a generalist cross-cluster coordination role. By their second project (SAFE-N-MEDTECH, 2019–2023), their focus had sharpened considerably: all recorded keywords point to a specific health-technology domain — medical devices, in vitro diagnostics, and nanoenabled medical technologies. This suggests a deliberate move from broad cluster facilitation into a more defined niche at the intersection of nanotechnology and regulated health products.

CEBR appears to be specializing their cluster network toward the medical device and diagnostics industry, making them a potentially useful partner for consortia needing regional industry uptake in the medtech space.

How they like to work

CEBR has participated exclusively as a consortium partner — they have never led a project. With 40 unique partners across 17 countries spread over just two projects, they operate in large, diverse consortia rather than tight recurring partnerships. This profile is typical of a network-type NGO that joins consortia to provide stakeholder reach and dissemination pathways rather than technical research output.

CEBR has collaborated with 40 unique partners across 17 countries, a wide geographic spread for an organization with only two projects. Their Brussels base and pan-European mandate likely give them connections across multiple EU member state bioregional clusters.

What sets them apart

As a pan-European association of bioregions rather than a single research or industry actor, CEBR offers something few organizations can: structured access to multiple regional innovation clusters simultaneously. For a consortium needing regional industry uptake or multi-country stakeholder validation in the medtech or NMBP space, CEBR can open doors that a single university or company cannot. Their niche combination of bioregion governance experience and emerging medtech cluster engagement is uncommon among Brussels-based NGOs.

Highlights from their portfolio

• SAFE-N-MEDTECH
  Their largest project by far (EUR 492,500 — 83% of total funding), an Innovation Action targeting nano-safety testing for medical devices and IVD products, signaling a serious domain commitment beyond generic cluster work.
• CLUSTERNANOROAD
  Their entry into H2020, a Coordination and Support Action connecting European clusters around the NMBP economy — the foundational project that established their positioning in the nanotechnology cluster space.